Recalls / Active ingredient / Temozolomide

Temozolomide

7 FDA drug recalls involving the active ingredient “Temozolomide”.

Date	Class	Product	Firm
2026-03-03	Class II	Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Ph	Rising Pharma Holding, Inc.
2019-07-16	Class II	Temozolomide Capsules, 20 mg, packaged in a) 5-count bottle (NDC 67877-538-07), b) 14-count bottle (NDC 67877-	Deva Holding AS - Cerkezkoy Subesi
2019-07-16	Class II	Temozolomide Capsules, 180 mg, packaged in a) 5-count bottle (NDC 67877-541-07), b) 14-count bottle (NDC 67877	Deva Holding AS - Cerkezkoy Subesi
2019-07-16	Class II	Temozolomide Capsules, 100 mg, packaged in a) 5-count bottle (NDC 67877-539-07), b) 14-count bottle (NDC 67877	Deva Holding AS - Cerkezkoy Subesi
2019-07-16	Class II	Temozolomide Capsules, 140 mg, packaged in a) 5-count bottle (NDC 67877-540-07), b) 14-count bottle (NDC 67877	Deva Holding AS - Cerkezkoy Subesi
2019-07-16	Class II	Temozolomide Capsules, 250 mg, 5-count bottle, Rx only, Manufactured by: Deva Holding A.S., 1 Merkez Mahallesi	Deva Holding AS - Cerkezkoy Subesi
2019-07-16	Class II	Temozolomide Capsules, 5 mg, packaged in a) 5-count bottle (NDC 67877-537-07), b) 14-count bottle (NDC 67877-5	Deva Holding AS - Cerkezkoy Subesi